NOT-DA-23-026: Notice of NIDA Participation in RFA-NS-22-022, RFA-NS-22-023, RFA-NS-22-024, RFA-NS-22-025, "HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research"

Notice of NIDA Participation in RFA-NS-22-022, RFA-NS-22-023, RFA-NS-22-024, RFA-NS-22-025, "HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research"

Notice Number:

NOT-DA-23-026

Key Dates

Release Date:

July 5, 2023

Related Announcements

December 15, 2022 - Career Transition Award/Research Transition Award - HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research (K99/R00 Independent Clinical Trial Not Allowed). See NOFO RFA-NS-22-022.
December 15, 2022 - Career Transition Award/Research Transition Award - HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research (Independent Basic Experimental Studies with Humans Required). See NOFO RFA-NS-22-023.
December 15, 2022 - Career Transition Award/Research Transition Award - HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research to Promote Diversity (K99/R00 Independent Basic Experimental Studies with Humans Required). See NOFO RFA-NS-22-024.
December 15, 2022 - Career Transition Award/Research Transition Award - HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed). See NOFO RFA-NS-22-025.

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

The purpose of this Notice is to inform potential applicants that the National Institute on Drug Abuse (NIDA) is participating in RFA-NS-22-022, RFA-NS-22-023, RFA-NS-22-024, RFA-NS-22-025, "HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research," effective immediately.

The following sections of RFA-NS-22-022, RFA-NS-22-023, RFA-NS-22-024, and RFA-NS-22-025 have been modified to reflect NIDA's participation in these NOFOs.

Part 1. Overview Information

Components of Participating Organizations

National Institute on Drug Abuse (NIDA)

Assistance Listing Number(s)

93.279

Section VII. Agency Contacts

Scientific/Research Contact(s)

Lindsey Friend, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-402-1428
Email: [email protected]

Financial/Grants Management Contact(s)

Pam Fleming
National Institute on Drug Abuse (NIDA)
Telephone: 301- 480-1159
Email: [email protected]

All other aspects of these NOFOs remain unchanged.

Inquiries

Please direct all inquiries to:

Lindsey Friend, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-402-1428
Email: [email protected]